No Data
No Data
AIM ImmunoTech Adjusts Executive Compensation and Agreements
Express News | AIM ImmunoTech-Cash Portion of Equels' Short-Term Compensation Was Reduced From $750,000 to $650,000
Express News | AIM ImmunoTech- Compensation Committee of Board Reviewed Compensation Arrangements of CEO Thomas K. Equels
Advyzon Investment Management (AIM) Wins WealthManagement.com Industry Award for Model Marketplaces
Express News | Todd Deutsch: Ted Kellner Supplemented Previously Submitted Notice of Intent of Nominations to AIM ImmunoTech Board - SEC Filing
AIM ImmunoTech Announces That Analysis Of AMP-518 Complete Clinical Patient Data Underscores Ampligen's Potential To Improve The Post-COVID Condition Of Fatigue, And That This Would Be The Likely Subject Population For AIM's Planned Follow-up Clinical...
No Data
No Data